Cholesterol 1,2,3 skin test
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals is on short list of potential U.S. marketing partners for International Medical Innovations' Cholesterol 1,2,3 test. McNeil will market the three-minute, non-invasive cholesterol skin test in Canada; however, Toronto-based IMI says it is considering U.S. distribution deals with several other firms. Cholesterol 1,2,3 received FDA 510(k) clearance on June 24; it is indicated for use with standard blood testing for patients suspected of having severe coronary artery disease. Home version of the test is under development, IMI says...